Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Eric Raymond

2PUBLICATIONS

9CO-AUTHORS

Molecular targetsCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 06, 2021

GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functions.

Sonia Brun, Eloïne Bestion, Eric Raymond

|May 24, 2020

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer.

Eric Raymond, Catherine Thieblemont, Severine Alran

Pageof 1

Frequent Collaborators

1 joint publications

Sonia Brun

1 joint publications

Eloïne Bestion

1 joint publications

Zuzana Macek Jilkova

1 joint publications

Soraya Mezouar

1 joint publications

Marie Novello

1 joint publications

Gilles Lalmanach

1 joint publications

Gael Roth

1 joint publications

Jean-Pierre Baudoin

1 joint publications

Thomas Decaens

Frequent Collaborators

1 joint publications

Sonia Brun

1 joint publications

Eloïne Bestion

1 joint publications

Zuzana Macek Jilkova

1 joint publications

Soraya Mezouar

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on : Mar 12, 2014

See more related videos

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on : Mar 12, 2014

See more related videos